Výzkumný Ústav Organických Syntéz

What Výzkumný Ústav Organických Syntéz does

Výzkumný Ústav Organických Syntéz a.s. (VUOS) is a Czech specialty chemical contract manufacturer and testing laboratory headquartered in Rybitví, Czech Republic, operating continuously since 1941 and wholly owned by AGROFERT Group. The company offers vertically integrated services across four pillars: custom synthesis (process development through kilogram-to-ton-scale production, with specialty in phosgenation chemistry, heterogeneous and homogeneous catalysis, chiral and heterocyclic synthesis, and high-hazard reagent handling); catalogue sales of chemical intermediates (adamantanes, vinyl derivatives, benzimidazoles, indoles, quinoxalines, isocyanates, chloroformates); GMP-certified analytical services including a Bruker NMR-equipped control laboratory; and GLP-certified toxicology and ecotoxicology testing for pharmaceuticals, pesticides/biocides, medical devices, cosmetics, and REACH/CLP regulatory dossiers.

The technology base rests on multi-purpose production equipment spanning glass-lined and stainless-steel reactors (including 250–1600L phosgenation reactors up to 150°C and high-pressure autoclaves to 60 MPa/250°C), Clean Room Class D sterile capacity, and a fully equipped analytical platform (Bruker Avance III HD 400/500 MHz NMR, Shimadzu HPLC, GC, MS, ion chromatography). Quality and regulatory credentials — GMP (SÚKL), GLP (Ministry of Environment), ISO 9001:2016 (Bureau Veritas), ČSN EN ISO/IEC 17065:2013 product certification, EN ISO 10993 medical-device testing, and SÚJB mycotoxin handling — are co-located with manufacturing, enabling single-vendor delivery from route development through commercial supply and regulatory testing.

Revenue is generated through project-based custom synthesis contracts, recurring catalogue chemical sales (1–1000 kg tonnage), and fee-for-service analytical and toxicology testing, all priced on negotiated quotes under confidentiality and IP-protection frameworks. Customers span global pharmaceutical companies (APIs and intermediates), agrochemical producers (pesticide/biocide registration), medical-device manufacturers (ISO 10993 biological evaluation), and broader chemical producers requiring certification. Distribution is direct B2B enterprise sales supported by trade-fair presence (Medica, CPhI Worldwide) and a company website offering downloadable catalogues and annual reports. Approximately 190 employees operate from a single Rybitví site, with more than 20% dedicated to R&D and an affiliated Centrum Organické Chemie (COC) research subsidiary.

Name

Výzkumný Ústav Organických Syntéz

Legal name

Výzkumný ústav organických syntéz a.s.

Website

https://vuos.com

Company type

Private

Founded year

1941

Operating status

Operating

Headcount range

51–100 employees

Short description

VUOS a.s. is a Czech specialty chemical contract manufacturer and GLP/GMP-certified testing laboratory, wholly owned by AGROFERT Group, providing custom synthesis, chemical intermediates, analytical services, and toxicology testing to pharmaceutical, agrochemical, and medical-device clients worldwide.

Ownership category

akta.pro rank

Product category

Custom Organic Synthesis and Contract Chemical Testing Services

NAICS

All Other Chemical Product and Preparation Manufacturing (32599), Chemical and Allied Products Merchant Wholesalers (4246)

SIC

Industrial Organic Chemicals (2860), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)

akta.pro secondary industries

Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

• Custom organic synthesis
• GMP analytical testing
• GLP toxicology testing
• Chemical intermediates manufacturing
• REACH regulatory services

Headquarters

HQ city

Rybitvi

HQ country

Czechia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Custom synthesis services: End-to-end custom synthesis including process development, laboratory synthesis, pilot-scale and commercial-scale manufacturing, with analytical support. Priced project-based, serving pharmaceutical, agrochemical, and fine chemicals industries.
2. Catalogue/sale of chemical intermediates and reagents: VUOS as registration owner imports and markets a range of raw materials, offering some for resale. Catalogue includes adamantanes, vinyl derivatives, benzimidazoles, indoles, quinoxalines, isocyanates, chloroformiates, and other fine chemicals. Tonnage range 1-1000 kg.
3. GMP analytical and contract testing services: Certified GMP control laboratory providing chemical/physical testing of pharmaceutical and veterinary products. Services include method development per ICH and pharmacopeial requirements, validation/verification, routine testing, and stability studies under GMP conditions.
4. Quality control and specialized analytical testing: Full-service analytical support for organic and inorganic substances across various matrices. Routine and specialized analyses for chemical and pharmaceutical production, including mycotoxin testing (with SÚJB license), pesticide/biocide testing, and product certification.
5. Toxicology and ecotoxicology testing: GLP-certified testing services for pesticides, biocides, medical devices, pharmaceuticals, and cosmetics under REACH and CLP regulations. Includes acute toxicity, genotoxicity, carcinogenicity, reproductive toxicity, and environmental fate studies.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Core offering

VUOS provides contract research and custom manufacturing services in organic chemistry, including custom synthesis of molecules at laboratory, pilot and industrial scale, a catalogue line of chemical intermediates and reagents, GMP-certified analytical and quality control testing, GLP-certified toxicology and ecotoxicology studies for pharmaceuticals, pesticides, medical devices and cosmetics, REACH and CLP regulatory services, and accredited product certification for personal protective equipment.

Product overview

VUOS is a mid-sized chemical research and manufacturing company (est. 1941, ~190 employees) offering a diversified portfolio of products and services. The core offerings include: (1) Custom synthesis services spanning process development, laboratory scale-up, and industrial-scale production; (2) A catalogue of chemical intermediates organized by compound class (adamantanes, vinyl derivatives, benzimidazoles, indoles, quinoxalines, isocyanates, chloroformates); (3) Analytical and quality control services including a GMP-certified laboratory; (4) Toxicology and safety testing services for pharmaceuticals, pesticides, biocides, medical devices, and cosmetics; (5) Regulatory services for REACH & CLP compliance; and (6) Product certification. The company operates multipurpose production facilities and specializes in phosgenation chemistry, catalytic hydrogenation, and heterocyclic synthesis.

Differentiator

Problem solved

Functional benefit

Named customers1 record

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• AGROFERT GroupcoreStrategic or Co-development PartnerVUOS is a 100% subsidiary of AGROFERT Group, one of the largest Czech agricultural and chemical conglomerates. The AGROFERT affiliation provides financial stability and strategic alignment within the broader chemical industry.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Eurofins Scientific: Global testing services group offering analytical, pharmaceutical, cosmetics, and medical device testing across many geographies. Comparable as a broad testing services incumbent to VUOS's analytical and toxicology testing lines.
• WuXi AppTec: Large global CRO/CDMO providing small-molecule API development and manufacturing, analytical and toxicology testing services. Comparable service categories (custom synthesis + testing) at much larger scale.
• Charles River Laboratories: Global CRO with a large safety assessment/toxicology testing business including GLP-certified facilities, plus CDMO services. Comparable through its GLP toxicology testing offerings relevant to VUOS's toxicology service line.
• Evonik: German specialty chemicals company with a Health Care segment including API and CDMO services, plus broader fine chemicals and catalysis. Comparable through its specialty/contract pharmaceutical manufacturing and catalysis expertise.

Direct peers

• Cambrex (Symeres): Mid-sized CDMO (now owned by Permira as part of Symeres) providing custom small-molecule API development and manufacturing from clinical to commercial scale. Closely comparable in scale and service offering to VUOS.
• EUROAPI: European API CDMO spun out from Sanofi in 2022, focused on small-molecule API development and manufacturing, including complex and hazardous chemistries. Comparable as a European-headquartered CDMO serving global pharma with custom synthesis.
• Recipharm: Swedish CDMO offering contract development and manufacturing of APIs and finished dosage forms for pharma customers. Comparable as a European mid-sized CDMO serving global pharmaceutical outsourcing demand.
• CordenPharma: CDMO providing custom API manufacturing including high-potency and complex small molecules, with full GMP and analytical services. Comparable service portfolio covering API synthesis and analytical support for pharma customers.
• Sterling Pharma Solutions: UK-based CDMO specializing in small-molecule API development and manufacturing with hazardous chemistry capabilities. Comparable in scale and CDMO service offering to VUOS's custom synthesis business.
• Hovione: Portuguese mid-sized CDMO specializing in custom synthesis of complex small molecules and APIs, with similar expertise in particle engineering and GMP manufacturing for pharmaceutical customers. Highly comparable in scale and business model to VUOS.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/vuos

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Výzkumný Ústav Organických Syntéz